Omidubicel is a first-in-class, advanced nicotinamide-enabled stem cell therapy candidate being evaluated as the first potential…
Continue ReadingTag: Blood
Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) To Advance Initiatives that Address Healthcare Disparities in Blood Cancer Care and Treatment
NEW YORK and RYE BROOK, N.Y., March 29, 2022 /PRNewswire/ — Royalty Pharma plc (Nasdaq: RPRX)…
Continue Reading